Development of differentiation helper inducers for the differentiation therapy of cancer

Chinese Pharmaceutical Journal

Volumn 50, Issue 5, 1998, Pages 289-303

  Liau, Ming Cheng ^a   Huang, Li Jiau ^a   Lee, Jau Hong ^a   Chen, Sheng Chih ^a   Kuo, Sheng Chu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell differentiation agents; Differentiation helper inducers; Methylation enzymes; Nitroblue tetrazolium (NBT)

Indexed keywords

DIFFERENTIATION INDUCING FACTOR; DNA; ENZYME; NITROBLUE TETRAZOLIUM; PHENYLACETIC ACID DERIVATIVE; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; DRUG POTENCY; GENE ACTIVATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE;

EID: 0031795554     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Potter, V. R. Phenotypic Diversity in Experimental Hepatoma-concept of Partially Blocked Ontogeny. Br. J. Cancer 1978, 38, 1-23.
2. Prehn, R. T. Cancers Beget Mutations Versus Mutations Beget Cancers. Cancer Res. 1994, 54, 5296-5300.
3. Liau, M. C.; Lin, G. W.; Hurlbert, R. B. Partial Purification and Characterization of Tumor and Liver S-Adenosylmethionine Synthetases. Cancer Res. 1977, 37, 423-435.
4. Liau, M. C.; Chang, C. F.; Becker, F. F. Alteration of 5-Adenosylmethionine Synthetase During Chemical Hepatocarcinogenesis and in Resulting Carcinomas. Cancer Res. 1979, 39, 2113-2119.
5. Liau, M. C.; Chang, C. F.; Giovanella, B. D. Demonstration of an Altered S-Adenosylmethionine Synthetase in Human Malignant Tumors Xenografted into Athymic Nude Mice. J. Natl. Cancer Inst. 1980, 64, 1071-1075.
6. Liau, M. C.; Lee, S. S.; Burzynski, S. R. Modulation of Cancer Methylation Complex Isozymes as a Decisive Factor in the Induction of Terminal Differentiation Mediated by Antineoplaston A5. Intl. J. Tiss. React, 1990, 12 (Suppl.), 27-36.
7. Liau, M. C.; Lee, S. S.; Burzynski, S. R. Hypomethylation of Nucleic Acids: A Key to the Induction of Terminal Differentiation. Intl. J. Exptl. Clin. Chemother. 1989, 2, 187-199.
8. Liau, M. C.; Chang, C. F.; Saunders, G. P.; Tsai, Y. H. S-Adenosylhomocysteine Hydrolases as the Primary Target Enzymes in Androgen Regulation of Methylation Complexes. Arch. Biochem. Biophys. 1981, 208, 261-272.
9. Liau, M. C.; Burzynski, S. R. Altered Methylation Complex Isozymes as Selective Targets for Cancer Chemotherapy. Drugs Exptl. Clin. Res. 1986, 12 (Suppl. 1), 77-86.
10. De La Rosa, J.; Geller, A. M.; Legros, H. L.; Kotb, M. Induction of Interleukin 2 Production But not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Tunover in Jurkat T-cells. Cancer Res. 1992, 52, 3361-3366.
11. Chiba, P.; Wallner, L.; Kaiser, E. S-Adenosylmethionine Metabolism in HL-60 Cells.: Effect of Cell Cycle and Differentiation. Biochim. Biophys. Acta. 1988, 971, 38-45.
12. Christman, J. K. DNA Methylation in Friend Erythroleukemia: The Effects of Chemically Induced Differentiation and of Treatment with Inhibitors of DNA methylation. Curr. Topics Microbiol. Immunol. 1984, 108, 49-78.
13. Jones, P. A.; Taylor, S. M. Cellular Differentiation, Cytidine Analogs and DNA Methylation. Cell 1984, 2, 85-93.
14. Huang, M. E.; Ye, Y. C.; Chen, S. R.; Chai, J. R.; Lu, J. X.; Zhao, L.; Gu, L. J.; Wang, Z. Y. Use of All-trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia. Blood 1988, 72, 567-572.
15. Warrell, R. P.; Frankel, S. R.; Miller, W. H.; Sheinberg, D. A.; Itri, L. M.; Hettleman, W. N.; Vyas, R.; Andreeff, M.; Tafuri, A.; Jakubowski, A.; Gabrilove, J.; Gordon, M. S.; Dmitrovsky, E. Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin(all-trans-retinoic acid). N. Eng. J. Med. 1991, 324, 1385-1393.
16. Quesada, J. R.; Reuben, J.; Manning, J. T.; Hersch, E. M.; Gutterman, J. Alpha Interferons for Induction of Remission in Hairy Cell Leukemia. N. Eng. J. Med. 1984, 310, 15-20.
17. Burzynski, S. R.; Kubove, E. Initial Clinical Study with Antineoplaston A2 Injections in Cancer Patients with Five Years Follow-up. Drugs Exptl. Clin. Res. 1987, 13 (Suppl. 1), 1-11.
18. Sano, K. Astonishing Efficacy of Cancer Therapy by CDA-II. in Conquest of Cancer; Tokuma Books: Tokyo, pp 18-43 and Shy Mon Publishing Co.: Taipei, 1997; pp 226-231.
19. Liau, M. C.; Lee, S. S. Burzynski, S. R. Differentiation Inducing Components of Antineoplaston A5. Adv. Exptl. Clin. Chemother. 1988, 6/88, 9-25.
20. Liau, M. C.; Liau, C. P.; Burzynski, S. R. Potentiation of Induced Terminal Differentiation by Phenylacetic Acid and Related Chemicals. Intl. J. Exptl. Clin. Chemother. 1992, 5, 9-17.
21. Samid, D. S.; Slack, S.; Sherman, L. T. Phenylacetate: A Novel Nontoxic Inducer of Tumor Cell Differentiation. Cancer Res. 1992, 52, 1988-1992.
22. Liau, M. C.; Szopa, M.; Burzynski, B.; Brzynski, S. R. Quantitative Assay of Plasma and Urinary Peptides as an Aid for the Evaluation of Cancer Patients Undergoing Antineoplaston Therapy. Drugs Exptl. Clin. Res. 1987a, 12 (Suppl. 1), 61-70.
23. Liau, M. C.; Szopa, M.; Burzynski, B.; Burzynski, S. R. Chemosurveillance: A Novel Concept of the Natural Defense Mechanism Against Cancer. Drugs Exptl. Clin. Res. 1987b, 12 (Suppl. 1), 71-76.
24. Burzynski, S. R. Treatment of Malignant Brain Tumors with Antineoplastons. Adv. Exptl. Clin. Chemother. 1988, 6/88, 45-46.
25. Sugita, Y.; Tsuda, H.; Maruiwa, H.; Hirohata, M.; Shigemori, M.; Hara, H. The Effect of Antineoplaston, a New Antitumor Agent on Malignant Brain Tumor. Kurume Med. J. 1995, 42, 133-140.
26. Thibault, A.; Samid, D.; Croper, M. D.; Figg, W. P.; Tompkins, A. C.; Patronas, N.; Headlee, P. J.; Kohler, D. R.; Venzon, D. J.; Myers, C. E. Phase I Study of Phenylacetate Administered Twice Daily to Patients with Cancer. Cancer 1995, 35, 2932-2938.
27. Lee, S. S.; Burynski, S. R. Induction of Differentiation of HL-60 Human Promyolocytic Leukemia Cells by Antineoplaston A5. Intl. J. Tiss. React. 1990, 12 (suppl.), 37-42
28. Singer, J.; Stellwagen, R. H.; Robert-Ems, J.; Riggs, A. D. 5-Methylcytosine Content of Rat Hepatoma DNA Substituted with Bromodeoxyuridine. J. Biol. Chem. 1997, 252, 5509-5513.
29. Muindi, J. R. F.; Frankel, S. R.; Huselton, C.; Degrazoa, F.; Garland, W. A.; Yiuug, C. W.; Warrel, R. P. J. Clinical Pharmacology of Oral All-trans-retinoic Acid in Patients with Acute Promyelocytic Leukemia. Cancer Res. 1992, 52, 2138-2142.
30. Burzynski, S. R.; Kubove, E.; Burzynski, B. Treatment of Hormonally Retractory Cancer of the Prostate with Antineoplaston AS2-1. Drugs Exptl. Clin. Res. 1990, 16, 361-369.
31. Tsuda, H.; Iemura, A.; Sata, M.; Uchida, M.; Yamana, K.; Hara, H. Inhibitory Effect of Antioneoplaston A10 and AS2-1 on Human Hepatocellular Carcinoma. Kurume Med. J. 1996, 43, 137-147.
32. Friend, C.; Zajar, K. M.; Holland, J. G.; Pogo, B. G. T. Depletion of Sodium Butyrate from the Culture Medium of Friend Erythroleukemia Cells Undergoing Differentiation. Cancer Res. 1987, 47, 378-382.